<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1271.html">Part 1271
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1271.1  What are the purpose and scope of this part?
                            </h3>
                            <p class="depth1"><em>(a)</em> of this  chapter, is to create a unified registration and listing system for  establishments that manufacture human cells, tissues, and cellular and  tissue-based products (HCT/P's) and to establish donor-eligibility,  current good tissue practice, and other procedures to prevent the  introduction, transmission, and spread of communicable diseases by HCT/ P's.</p><p class="depth1"><em>(b)</em> Scope. </p><p class="depth2"><em>(1)</em> If you are an establishment that manufactures HCT/P's  that are regulated solely under the authority of section 361 of the  Public Health Service Act (the PHS Act), this part requires you to  register and list your HCT/P's with the Food and Drug Administration's  (FDA's) Center for Biologics Evaluation and Research and to comply with  the other requirements contained in this part, whether or not the HCT/P  enters into interstate commerce. Those HCT/P's that are regulated solely  under the authority of section 361 of the PHS Act are described in Sec.  1271.10.</p><p class="depth2"><em>(2)</em> If you are an establishment that manufactures HCT/P's that are  regulated as drugs, devices and/or biological products under section 351  of the PHS Act and/or the Federal Food, Drug, and Cosmetic Act,  Sec. Sec. 207.20(f) and 807.20(d) of this chapter require you to  register and list your HCT/P's following the procedures in subpart B of  this part. Sections 210.1(c), 210.2, 211.1(b), and 820.1(a) of this  chapter require you to comply with the donor-eligibility procedures in  subpart C of this part and the current good tissue practice procedures  in subpart D of this part, in addition to all other applicable  regulations.  [66 FR 5466, Jan. 19, 2001, as amended at 69 FR 29829, May 25, 2004]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
